Forward Pharma A/S logo
Forward Pharma A/S FWP

Annual report 2021
added 12-23-2023

report update icon

Forward Pharma A/S Gross Profit 2011-2026 | FWP

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Forward Pharma A/S

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 1.22 B - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.22 B 1.22 B 1.22 B

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
473 M $ 22.56 2.13 % $ 3.74 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
2.32 M - - $ 86.2 M usaUSA
argenx SE argenx SE
ARGX
2.68 M $ 785.07 2.57 % $ 25 B niderlandNiderland
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
5.51 M - 2.54 % $ 160 B franceFrance
Akebia Therapeutics Akebia Therapeutics
AKBA
190 M $ 1.43 3.62 % $ 368 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
195 M $ 327.25 2.42 % $ 42.9 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
177 K $ 3.9 3.7 % $ 9.38 B australiaAustralia
Advaxis Advaxis
ADXS
90 K - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
356 M $ 20.4 -0.87 % $ 954 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
32.9 M $ 4.18 1.21 % $ 447 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
45.8 M $ 2.66 3.5 % $ 16.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
48.1 B - - $ 96.9 B britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
BeiGene, Ltd. BeiGene, Ltd.
BGNE
4.67 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
4.73 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Cabaletta Bio Cabaletta Bio
CABA
0.006 $ 3.09 0.65 % $ 310 M usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
2.92 K - -55.98 % $ 2.15 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
7.32 M - - $ 789 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
10 K - 1.93 % $ 17.4 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
1.07 - - $ 169 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
5.48 M $ 32.41 3.38 % $ 2.15 B usaUSA
Celsion Corporation Celsion Corporation
CLSN
500 K - -6.63 % $ 13.9 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-10.6 M - - $ 867 M germanyGermany
Chimerix Chimerix
CMRX
324 K - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
7.9 K - - $ 401 M usaUSA